Konstantinos Leventakos, MD, PhD, is a medical oncologist with a focus on thoracic malignancies, personalized medicine, and immunotherapy. His clinical focus includes, non-small cell lung cancer, small cell lung cancer, mesothelioma, thymic malignancies, neuroendocrine tumors, multidisciplinary approach to thoracic malignancies and personalized medicine, and the integration of Artificial Intelligence (AI) for clinical trial matching.

In addition to his clinical activities, Dr. Leventakos is active in research and education of medical students, residents, and oncology fellows. He publishes in many journals and speaks at many national and international meetings.

Yan Ji, MD, is an oncologist/hematologist at HealthPartners Medical Group, Regions Hospital. Dr. Ji's special interests include solid tumors, and lung, breast, and gastrointestinal cancers. Her many years of cancer research in these areas have deepened her understanding of underlying mechanisms that translate to the best treatment for patients.

Dr. Jasmine Kamboj is a board-certified Medical Oncologist and Hematologist at the Mayo Clinic Health System, Minnesota. She earned her medical degree from the Armed Forces Medical College, Pune, India. She trained in Internal Medicine at the Rosalind Franklin University of Medicine and Science, North Chicago and pursued a fellowship in Hematology and Oncology at the Baylor College of Medicine, Houston.

Dr. Kamboj has served on the Health Equity and Government Relations Committees at ASCO. She has been a strong advocate at the Capitol Hill for cancer related issues, like prior authorization, that directly impact cancer care and outcomes. Dr. Kamboj has been awarded “ASCO Advocate of the year Award,” and has been honored with the highest level of Advocacy Championship, “the President’s Circle.” She co-leads the ASCO Communities of Practice on Policy. She will be working on the ASCO International Affairs Committee for a term of 3 years, June 2024-27.

Balkrishna Jahagirdar, MD, is a board certified medical oncologist-hematologist. He is on the faculty of the Department of Medicine at the University of Minnesota, and serves as a member of the Experimental Therapeutics Committee of the Alliance for Clinical Trials in Oncology to help design and conduct clinical trials of new cancer treatments throughout the country.

Dr. Jahagirdar has co-authored a book chapter in the Textbook of Malignant Hematology, and his research is published in prestigious journals, including Nature, the Journal of Clinical Investigation, Blood, Experimental Hematology, and Leukemia.

He is a recipient of several awards and honors, including the Clinical Excellence Award of the University of Minnesota, Outstanding Clinical Mentor Award, National Cancer Institute's MetroMinnesota Community Clinical Oncology Program-Silver Certificate for his contribution to clinical trials in oncology, and the Blood and Marrow Transplant Award.